AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
Brigham and Women's Hospital · Presbyterian Hospital · +3 more institutions
Abstract
The 2001 update of the American Heart Association (AHA)/American College of Cardiology (ACC) consensus statement on secondary prevention, 1 important evidence from clinical trials has emerged that further supports and broadens the merits of aggressive risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. This growing body of evidence confirms that aggressive comprehensive risk factor management improves survival, reduces recurrent events and the need for interventional procedures, and improves quality of life for these patients.
Citation impact
- FWCI
- 197.97
- Percentile
- 100%
- References
- 72
Authors
15- SCSidney C. SmithCorresponding
Brigham and Women's Hospital, Presbyterian Hospital, Institute for Atherosclerosis Research, University of Rochester, World Heart Federation
- JKJerilyn K. Allen
Brigham and Women's Hospital, Presbyterian Hospital, Institute for Atherosclerosis Research, University of Rochester, World Heart Federation
- SNSteven N. Blair
Brigham and Women's Hospital, Presbyterian Hospital, Institute for Atherosclerosis Research, University of Rochester, World Heart Federation
- RORobert O. Bonow
Brigham and Women's Hospital, Presbyterian Hospital, Institute for Atherosclerosis Research, University of Rochester, World Heart Federation
- LBLawrence Brass
Brigham and Women's Hospital, Presbyterian Hospital, Institute for Atherosclerosis Research, University of Rochester, World Heart Federation
Topics & keywords
- Medicine
- ATHEROSCLEROTIC VASCULAR DISEASE
- Secondary prevention
- Atherosclerotic cardiovascular disease
- Internal medicine
- Cardiology
- Vascular disease
- Coronary artery disease
- Good health and well-being